CEO and President of Achillion Pharmaceuticals Inc. (ACHN, Financial) Michael D Kishbauch sells 99,109 shares of ACHN on 01/11/2012 at an average price of $10.24 a share.
Achillion Pharmaceuticals Inc. has a market cap of $829.9 million; its shares were traded at around $11.9 with and P/S ratio of 340.7.
For the complete insider trading history of ACHN, click here.
Achillion Pharmaceuticals Inc. has a market cap of $829.9 million; its shares were traded at around $11.9 with and P/S ratio of 340.7.
Directors and Officers Recent Trades:
- Director Dennis Liotta bought 5,000 shares of ACHN stock on 11/21/2011 at the average price of 5.96. Dennis Liotta owns at least 45,000 shares after this. The price of the stock has increased by 99.66% since.
- Director Dennis Liotta bought 10,000 shares of ACHN stock on 08/22/2011 at the average price of 5.39. Dennis Liotta owns at least 40,000 shares after this.
- SVP and Chief Compliance Ofc. Gautam Shah sold 10,423 shares of ACHN stock on 12/20/2011 at the average price of 7.69. Gautam Shah owns at least 3,125 shares after this. The price of the stock has increased by 54.75% since.
- SVP and Chief Compliance Ofc. Gautam Shah sold 2,078 shares of ACHN stock on 12/01/2011 at the average price of 7. Gautam Shah owns at least 3,125 shares after this. The price of the stock has increased by 70% since.
- SVP and Chief Compliance Ofc. Gautam Shah sold 2,719 shares of ACHN stock on 09/16/2011 at the average price of 5.9. Gautam Shah owns at least 3,125 shares after this.
For the complete insider trading history of ACHN, click here.
